Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients.
BACKGROUND: Despite considerable improvements in the care of patients with cardiovascular disease in various populations over the last few decades, there are still limited data about long-term treatment patterns among patients with various atherosclerotic vascular conditions in China, especially the...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|
| _version_ | 1797067074975039488 |
|---|---|
| author | Li, J Chen, Y Li, X Armitage, J Feng, F Liu, J Gao, Y Zhang, H Zhang, D Hundei, W Chen, Z Chen, F Hopewell, J Valdes-Marquez, E Landray, M Jiang, L |
| author_facet | Li, J Chen, Y Li, X Armitage, J Feng, F Liu, J Gao, Y Zhang, H Zhang, D Hundei, W Chen, Z Chen, F Hopewell, J Valdes-Marquez, E Landray, M Jiang, L |
| author_sort | Li, J |
| collection | OXFORD |
| description | BACKGROUND: Despite considerable improvements in the care of patients with cardiovascular disease in various populations over the last few decades, there are still limited data about long-term treatment patterns among patients with various atherosclerotic vascular conditions in China, especially the use of statin therapy. METHODS: Between June 2007 and October 2009, 16 860 patients aged 50 - 80 years with established history of atherosclerotic vascular disease (coronary heart disease (CHD), atherosclerotic cerebrovascular disease (CVD), or peripheral arterial disease (PAD)) from 51 hospitals in 14 cities of China were screened for a large randomized trial. Detailed information about current use of statins and various other treatments was recorded and analyzed by prior disease history, adjusting for various baseline characteristics. RESULTS: Among the 16 860 patients, the mean age was 63 years and 74% were male. Overall, 78% of the patients had documented CHD, 40% had CVD, 5% had PAD and 21% reported more than one condition. The median time from initial diagnosis of vascular disease to screening was 18 months. At screening, the proportions who took various treatments were 83% for antiplatelet agents, 49% for beta-blockers, 47% for statins and 28% for angiotensin-converting enzyme inhibitors. The proportion treated with statin was much higher in CHD than in CVD or PAD patients (61% vs. 10% vs. 22% respectively) and decreased significantly with time from initial diagnosis. Simvastatin (mainly 20 mg) and atorvastatin (mainly 10 mg) each accounted for about 40% of total statin use. CONCLUSIONS: In urban China, there is still significant underuse of various proven secondary preventive therapies, with particularly low use of statins in patients with ischaemic stroke. |
| first_indexed | 2024-03-06T21:51:07Z |
| format | Journal article |
| id | oxford-uuid:4b4bf53c-0065-496b-a774-c7155dd8e778 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:51:07Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:4b4bf53c-0065-496b-a774-c7155dd8e7782022-03-26T15:42:44ZUse of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4b4bf53c-0065-496b-a774-c7155dd8e778EnglishSymplectic Elements at Oxford2012Li, JChen, YLi, XArmitage, JFeng, FLiu, JGao, YZhang, HZhang, DHundei, WChen, ZChen, FHopewell, JValdes-Marquez, ELandray, MJiang, LBACKGROUND: Despite considerable improvements in the care of patients with cardiovascular disease in various populations over the last few decades, there are still limited data about long-term treatment patterns among patients with various atherosclerotic vascular conditions in China, especially the use of statin therapy. METHODS: Between June 2007 and October 2009, 16 860 patients aged 50 - 80 years with established history of atherosclerotic vascular disease (coronary heart disease (CHD), atherosclerotic cerebrovascular disease (CVD), or peripheral arterial disease (PAD)) from 51 hospitals in 14 cities of China were screened for a large randomized trial. Detailed information about current use of statins and various other treatments was recorded and analyzed by prior disease history, adjusting for various baseline characteristics. RESULTS: Among the 16 860 patients, the mean age was 63 years and 74% were male. Overall, 78% of the patients had documented CHD, 40% had CVD, 5% had PAD and 21% reported more than one condition. The median time from initial diagnosis of vascular disease to screening was 18 months. At screening, the proportions who took various treatments were 83% for antiplatelet agents, 49% for beta-blockers, 47% for statins and 28% for angiotensin-converting enzyme inhibitors. The proportion treated with statin was much higher in CHD than in CVD or PAD patients (61% vs. 10% vs. 22% respectively) and decreased significantly with time from initial diagnosis. Simvastatin (mainly 20 mg) and atorvastatin (mainly 10 mg) each accounted for about 40% of total statin use. CONCLUSIONS: In urban China, there is still significant underuse of various proven secondary preventive therapies, with particularly low use of statins in patients with ischaemic stroke. |
| spellingShingle | Li, J Chen, Y Li, X Armitage, J Feng, F Liu, J Gao, Y Zhang, H Zhang, D Hundei, W Chen, Z Chen, F Hopewell, J Valdes-Marquez, E Landray, M Jiang, L Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients. |
| title | Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients. |
| title_full | Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients. |
| title_fullStr | Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients. |
| title_full_unstemmed | Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients. |
| title_short | Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients. |
| title_sort | use of secondary preventive medications in patients with atherosclerotic disease in urban china a cross sectional study of 16 860 patients |
| work_keys_str_mv | AT lij useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT cheny useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT lix useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT armitagej useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT fengf useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT liuj useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT gaoy useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT zhangh useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT zhangd useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT hundeiw useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT chenz useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT chenf useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT hopewellj useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT valdesmarqueze useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT landraym useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients AT jiangl useofsecondarypreventivemedicationsinpatientswithatheroscleroticdiseaseinurbanchinaacrosssectionalstudyof16860patients |